Late mortality and morbidity among long-term leukemia survivors with Down syndrome: A nationwide population-based cohort study.

In this study, we found that relapse was the main reason for death and hospitalization among leukemia survivors with DS, and not late effects. These results are reassuring for individuals treated for DS associated with leukemia and their parents.